Dr. Aruna Kumar Subramanian, MD

Dr. Subramanian practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Subramanian's NPI, 1356371082, was assigned on July 5, 2006. Dr. Subramanian graduated from University Of Michigan Medical School in 1994. Dr. Subramanian's California license number on file is C56151.

Dr. Subramanian's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Subramanian's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Subramanian to 1 more hospital, named with a free account. Dr. Subramanian's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Subramanian practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Subramanian's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Subramanian is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Subramanian's licenses on file in 3 states: California, Maryland and Ohio.

Dmand AI lists acute skin infection, immune deficiency disease and joint or bone infection among the conditions Dr. Subramanian treats.

CMS data shows 264 Medicare services from Dr. Subramanian across 5 procedure codes in 2024, for 134 Medicare patients. Medicare paid $34,732 for them.

CMS counts 134 Medicare patients who saw Dr. Subramanian in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 43% are also on Medicaid. Their average risk score is 4.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Subramanian's median patient age at 58, with 51% women.

In 2024, Dr. Subramanian wrote 124 Medicare Part D claims for 27 patients. 87% of them were for generic drugs. CMS names the drug for 43 of them, across 3 drugs with 11 or more claims each, at $3,827 in total drug cost. In 2023, CMS named 34 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Subramanian for performance year 2024, reported as part of a group. Dr. Subramanian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Subramanian as offering telehealth.

Dmand AI links 66 papers to Dr. Subramanian, published from 2008 to 2024. 2020 was the busiest year, with 7. The most frequent topics are COVID-19, Organ Transplantation and SARS-CoV-2. Dr. Subramanian has published most often in Transpl Infect Dis. Dr. Subramanian's most frequent co-authors are Hector F. Bonilla, MD, Prasanna Jagannathan, MD and Catherine Anne Blish, MD.

CMS Open Payments shows 3 general payments to Dr. Subramanian from 3 drug and device companies from 2016 to 2023. Honoraria make up the largest share, 72% of the total. Pfizer Inc. paid the most, $3,500. It also lists 1 research payment totaling $7,228 in 2025.

Dmand AI lists 1 award for Dr. Subramanian, most recently CMS Stage 1 EHR in 2013.

Dr. Subramanian graduated from University Of Michigan Medical School in 1994.

Dr. Subramanian is in network with 9 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.